§ Federal grant opportunity · HT942526CRRPTRA
DOW Combat Readiness – Medical Research Program Translational Research Award
Danielle Reckley Grantor is accepting applications for DOW Combat Readiness – Medical Research Program Translational Research Award. The deadline is November 18, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Danielle Reckley Grantor
- Application deadline
- November 18, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526CRRPTRA
Program overview
Summary: The fiscal year 2026 (FY26) Combat Readiness – Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven innovative, high-impact translational research that will accelerate the movement of promising ideas and/or technologies in trauma care into solutions to maximize casualty survivability, improve patient care closer to the point of injury and/or trauma care guidelines. Preliminary data are required. Research using well-validated animal models is allowed. Distinctive Features: • **NEW for FY26** An investigator may be named as the Principal Investigator (PI) on only one FY26 CRRP TRA application. • Research supported by the FY26 CRRP TRA must represent a mature, translational research effort with a minimum biomedical technology readiness level (TRL) of 4 or knowledge readiness level (KRL) of 4.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Danielle Reckley Grantor.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before November 18, 2026, allowing time for registration and validation.
Related grant opportunities
- DoW Orthopaedic, Clinical Research Award
- DoW Rare Cancers Idea Development Award
- DoW Orthopaedic, Applied Research Award
- DoW Rare Cancers Resource and Community Development Award
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.